Unlocking Better Health Worldwide
What started as a vision to make quality medicines accessible has grown into a global pharmaceutical organization.
From lab
to market
Developing
Built to
global standards
Manufacturing
Reaching every
market
Distribution
Aardvark signs deal to commercialize two Oncology Drugs in Saudi Arabia
With a global market cap of $8B USD, Aardvark Pharma plans to take significant market share beginning in 2028 (May 2026).
Aardvark begins R&D for 10 drugs for its USA portfolio
Aardvark Pharma initiates research to register 10 oncology drugs with the US FDA by 2032 (October 2025).
Aardvark commits to register pain medication with Mexico Cofepris by 2027
With an annual market cap of $1B USD, Aardvark Pharma plans to achieve large market share over its commercialization (February 2025).
“
Every medicine we bring to market is a promise kept – to patients, to progress, and to a healthier world.”
Suraj Khatau
Managing Director at Aardvark